FABP4

There are 71 papers on FABP4 in aging research: 4 trials and 19 observational studies in people, 35 in animals, 11 in cells, 2 reviews. The newest story, Oct 11, 2026: “Poor heart and metabolic health with frailty linked to heart failure”.

Gene

71 papers study it23 findings

HGNCNCBI GeneTaxon

7 new papers in 30 daysSee all 71 papers on FABP4

At a glance

The findings reach people, from one lab or study. 14 independent labs in 8 countries.

“FABP4 yielded the largest positive mediated proportions (AF, 49.8%; HF, 32.9%) and transition-specific signals for baseline-to-AF and AF-to-comorbidity.”
Cardiometabolic health-frailty phenotypes and bidirectional transitions between atrial fibrillation and heart failure: multistate trajectories and proteomic signaturesThe journal of nutrition, health & aging2026doi:10.1016/j.jnha.2026.101006

None of its findings points the other way.

Cells, mice and humans: a single group. Worms or flies: nothing yet.
  • 14 independent labs in 8 countries
  • Funders: National Institutes of Health and others
  • Human trial4
  • Humans19
  • Animals35
  • Cells11

Interventions

3

High-fat diet

upin mice1

1 study
  1. High-fat diet increases FABP4 in mice during aging.

    “bone marrow macrophages of the LHA group upregulated Chil3 and Fabp4”

    Animalsduring agingbone marrow macrophages

    Long-Term High-Fat Diet Affected Bone Marrow Microenvironment During Aging at Single-Cell Resolution

    MedComm

More on High-fat diet

Elamipretide

downin human cells1

1 study
  1. Elamipretide decreases FABP4 in degenerative tenocytes.

    “fatty acid-binding protein 4 (fatty infiltration, P = .046) was significantly upregulated in the degenerative tenocytes and reduced by SS-31 treatment (P = .048; P = .007)”

    Cellsin degenerative tenocytes1μM72 hours

    Evaluation of SS-31 as a Potential Strategy for Tendinopathy Treatment: An In Vitro Model

    The American journal of sports medicine

More on Elamipretide

Docosahexaenoic acid

downin human cells1

1 study
  1. Docosahexaenoic acid decreases FABP4 in human Mesenchymal Stromal Cells during treatment with rosiglitazone.

    “confirming the beneficial effect of docosahexaenoic acid (DHA) omega-3 FA during treatment with rosiglitazone, through the down-regulation of adipogenic genes”

    Cellsin human Mesenchymal Stromal Cells during treatment with rosiglitazone

    Omega-3 fatty acid-rich fish oil supplementation prevents rosiglitazone-induced osteopenia in aging C57BL/6 mice and in vitro studies

    Scientific reports

More on Docosahexaenoic acid

Effects

12

Cellular senescence

is required forin human cells1upin human cells1

2 studies
  1. FABP4 is required for cellular senescence in human cells (shown by functional inhibition of FABP4 protein in PFOS-treated HTMCs).

    “Crucially, targeted functional inhibition of the FABP4 protein successfully rescued PFOS-induced senescence and downregulated P21 expression.”

    Cellsshown by functional inhibition of FABP4 protein in PFOS-treated HTMCstrabecular meshwork

    Perfluorooctanesulfonic acid contributes to primary open-angle glaucoma in a FABP4-Dependent manner: a novel mechanism for environmental risk of glaucoma

    Frontiers in genetics

  2. FABP4 induces cellular senescence in human cells (FABP4 overexpression).

    “FABP4 overexpression promoted human LO2 cell senescence.”

    CellsFABP4 overexpression

    Targeting FABP4 in elderly mice rejuvenates liver metabolism and ameliorates aging-associated metabolic disorders

    Metabolism: clinical and experimental

More on Cellular senescence

CTRP3 ubiquitination-associated proteasomal degradation

upin mouse cells1

1 study
  1. FABP4 increases CTRP3 ubiquitination-associated proteasomal degradation in vitro.

    “In vitro, FABP4 interacted with CTRP3 and promoted CTRP3 ubiquitination-associated proteasomal degradation.”

    Cellsin vitro

    Swimming exercise protects against diabetic cardiomyopathy through suppression of FABP4-associated CTRP3 degradation

    Cellular signalling

Atrial fibrillation

mediatesin humans1

1 study
  1. FABP4 is linked with atrial fibrillation in humans (positive mediated proportions) (49.8% mediated proportion for AF, 32.9% for HF).

    “FABP4 yielded the largest positive mediated proportions (AF, 49.8%; HF, 32.9%) and transition-specific signals for baseline-to-AF and AF-to-comorbidity.”

    Humanspositive mediated proportions

    Poor heart and metabolic health with frailty linked to heart failure

    The journal of nutrition, health & aging

More on Atrial fibrillation

Cardiovascular disease

mediatesin humans1

1 study
  1. FABP4 is linked with cardiovascular disease in Stage 2 CKM syndrome (24.6% mediated).

    “FABP4 (24.6%) in Stage 2”

    Humansin Stage 2 CKM syndrome

    A Stage-Ordered Multi-Omic Continuum Underlies Cardiovascular-Kidney-Metabolic Syndrome and the Protective Association of Cardiovascular Health

    medRxivPreprint

More on Cardiovascular disease

Senescent CD8+ T cells

upin human cells1

1 study
  1. FABP4 induces senescent CD8+ T cells in OvCa microenvironment.

    “adipocyte-derived factors (MATES) and oleic acid (OA)-the predominant fatty acid in OvCa ascites-promoted tumor-induced CD8+Tsen formation by enhancing fatty acid (FA) uptake via FABP4”

    Cellsin OvCa microenvironment

    Fatty acid uptake mediated by FABP4 promotes the formation of CD8⁺T cell senescence through lipid peroxidation in the adipocyte-rich microenvironment of Ovarian Cancer

    Oncogenesis

More on Senescent CD8+ T cells

CXCR4

downin mouse cells1

1 study
  1. FABP4 decreases CXCR4 in mouse cells.

    “treatment with FABP4 in bone marrow cells increased inhibitory T cells while decreased SDF-1 receptor, CXCR4 in EPCs”

    Cellsbone marrow

    Age-associated T cell immunity decreases circulating endothelial progenitor cells

    Stem cells (Dayton, Ohio)

More on CXCR4

Inhibitory T cells

upin mouse cells1

1 study
  1. FABP4 increases inhibitory T cells in mouse cells.

    “treatment with FABP4 in bone marrow cells increased inhibitory T cells while decreased SDF-1 receptor, CXCR4 in EPCs”

    Cellsbone marrow

    Age-associated T cell immunity decreases circulating endothelial progenitor cells

    Stem cells (Dayton, Ohio)

More on Inhibitory T cells

Circulating endothelial progenitor cells

downin mice1

1 study
  1. FABP4 decreases circulating endothelial progenitor cells in aging.

    “FABP4-mediated decrease of circulating EPC in aging were restored by therapeutic administration of mitochondria”

    Animalsin aging

    Age-associated T cell immunity decreases circulating endothelial progenitor cells

    Stem cells (Dayton, Ohio)

More on Circulating endothelial progenitor cells

Angiogenesis

upin reviews1

1 study
  1. FABP4 induces angiogenesis.

    “FABP4 induces angiogenesis and vascular smooth muscle cell proliferation and migration.”

    Review

    The Effects of FABP4 on Cardiovascular Disease in the Aging Population

    Current atherosclerosis reports

More on Angiogenesis

Inflammation

upin mice1

1 study
  1. FABP4 increases inflammation in mice (shown by Fabp4/5 deficiency).

    “Fabp-deficient mice exhibit extended metabolic healthspan, with protection against insulin resistance and glucose intolerance, inflammation, deterioration of adipose tissue integrity, and fatty liver disease.”

    Animalsshown by Fabp4/5 deficiencyadipose tissue

    Uncoupling of Metabolic Health from Longevity through Genetic Alteration of Adipose Tissue Lipid-Binding Proteins

    Cell reports

More on Inflammation

All 12

Upstream

2

Old age

downin mice1

1 study
  1. old age decreases FABP4 in mice (cardiac Schwann cells).

    “lower gene and protein expression levels of the fatty acid co-transporter Fabp4/FABP4 are detected in cardiac SC from old compared to young mice”

    Animalscardiac Schwann cellsheart

    Multi-level expression profiling of cardiac and musculoskeletal Schwann cells in young and old mice

    Journal of molecular and cellular cardiology

PPARG

upin cells1

1 study
  1. PPARG increases FABP4 in cells.

    “Age-induced loss of PPARgamma/SRC-1 interactions increased the binding of PPARgamma to the promoter of the adipogenic gene aP2.”

    Cellsvisceral white adipose tissue

    Aging alters PPARgamma in rodent and human adipose tissue by modulating the balance in steroid receptor coactivator-1

    Aging cell

More on PPARG

Associations

5

Conjugated linoleic acid

downin chickens1

1 study
  1. FABP4 is associated with conjugated linoleic acid in chickens (negative correlation).

    “it showed a negative correlation with conjugated linoleic acids (CLA)”

    Animalsovary

    Integrated analysis of transcriptome and metabolomic uncover molecular mechanisms of ovarian aging in laying hens

    Poultry science

More on Conjugated linoleic acid

Fatty liver disease

upin mice1

1 study
  1. FABP4 raises the risk of fatty liver disease in mice (shown by Fabp4/5 deficiency).

    “Fabp-deficient mice exhibit extended metabolic healthspan, with protection against insulin resistance and glucose intolerance, inflammation, deterioration of adipose tissue integrity, and fatty liver disease.”

    Animalsshown by Fabp4/5 deficiencyadipose tissue

    Uncoupling of Metabolic Health from Longevity through Genetic Alteration of Adipose Tissue Lipid-Binding Proteins

    Cell reports

More on Fatty liver disease

Insulin resistance

upin mice1

1 study
  1. FABP4 raises the risk of insulin resistance in mice (shown by Fabp4/5 deficiency).

    “Fabp-deficient mice exhibit extended metabolic healthspan, with protection against insulin resistance and glucose intolerance, inflammation, deterioration of adipose tissue integrity, and fatty liver disease.”

    Animalsshown by Fabp4/5 deficiencyadipose tissue

    Uncoupling of Metabolic Health from Longevity through Genetic Alteration of Adipose Tissue Lipid-Binding Proteins

    Cell reports

More on Insulin resistance

Arterial stiffness

upin humans1

1 study
  1. FABP4 is associated with arterial stiffness in kidney transplant patients.

    “Serum fasting A-FABP level is positively associated with peripheral arterial stiffness in KT patients.”

    Humansin kidney transplant patientsn = 74

    Serum adipocyte fatty acid-binding protein level is associated with arterial stiffness quantified with cardio-ankle vascular index in kidney transplant patients

    Clinical and experimental nephrology

Cardio-ankle vascular index

upin humans1

1 study
  1. FABP4 predicts cardio-ankle vascular index in kidney transplant patients (p = 0.003).

    “Multivariate forward stepwise linear regression analysis showed that age (p = 0.004), systolic blood pressure (p = 0.001), and serum A-FABP levels (p = 0.003) were independent predictors of CAVI value in KT patients.”

    Humansin kidney transplant patientsn = 74

    Serum adipocyte fatty acid-binding protein level is associated with arterial stiffness quantified with cardio-ankle vascular index in kidney transplant patients

    Clinical and experimental nephrology

More on Cardio-ankle vascular index

Latest

Dec 2025: 2Jan 2026: 1Feb 2026: 2Mar 2026: 2Apr 2026: 0May 2026: 2Jun 2026: 1Jul 2026: 0Aug 2026: 4Sep 2026: 0Oct 2026: 6Nov 2026: 323 papers in 12 months
The Journal of Nutrition, Health & Aging

Poor heart and metabolic health with frailty linked to heart failure

People with poor heart and metabolic health and pre-frailty or frailty had a heart failure hazard ratio of 2.76 versus healthy, non-frail participants.People with poor heart and metabolic health and pre-frailty or frailty had a heart failure hazard ratio of 2.76 versus healthy, non-frail participants.

Cohort study of 319,048 peopleHeart failure
Advanced Science

Intramuscular fat links to spinal muscle loss and weakness

People with intramuscular fat fractions above 10% showed significantly lower paraspinal muscle mass and strength than those with levels below 5%.People with intramuscular fat fractions above 10% showed significantly lower paraspinal muscle mass and strength than those with levels below 5%.

Cross-sectional study in peopleMuscle

See all 71 papers on FABP4